Floatz logo

Therapeutic Asset Ratings

394 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
mk-5684
Metastatic Neoplasm
Merck Sharp & Dohme LLCP1/2CC (45)
Patritumab Deruxtecan
Cancer
Merck Sharp & Dohme LLCP1/2CC (45)
Zilovertamab Vedotin
Ewing Sarcoma
Merck Sharp & Dohme LLCP1/2CC (45)
Zilovertamab Vedotin
Neuroblastoma
Merck Sharp & Dohme LLCP1/2CC (45)
Cyclophosphamide
Advanced/Metastatic Solid Tumors
Merck Sharp & Dohme LLCP1CC (44)
Elpipodect
Bipolar I Disorder
Merck Sharp & Dohme LLCP1CC (44)
Epirubicin
Advanced/Metastatic Solid Tumors
Merck Sharp & Dohme LLCP1CC (44)
mk-4464
Advanced/Metastatic Solid Tumors
Merck Sharp & Dohme LLCP1CC (44)
mk-4700
Cancer
Merck Sharp & Dohme LLCP1CC (44)
MK8189
Schizophrenia
Merck Sharp & Dohme LLCP1CC (44)
Cyclophosphamide
Programmed Cell Death 1 Ligand 1(PDL1, PD-L1)
Merck Sharp & Dohme LLCP1CC (43)
Cyclophosphamide
Programmed Cell Death 1 Ligand 2 (PDL2, PD-L2)
Merck Sharp & Dohme LLCP1CC (43)
Cyclophosphamide
Programmed Cell Death-1 (PD1, PD-1)
Merck Sharp & Dohme LLCP1CC (43)
Epirubicin
Programmed Cell Death 1 Ligand 1(PDL1, PD-L1)
Merck Sharp & Dohme LLCP1CC (43)
Epirubicin
Programmed Cell Death 1 Ligand 2 (PDL2, PD-L2)
Merck Sharp & Dohme LLCP1CC (43)
Epirubicin
Programmed Cell Death-1 (PD1, PD-1)
Merck Sharp & Dohme LLCP1CC (43)
GEH200520
Metastatic Neoplasm
Merck Sharp & Dohme LLCP1CC (43)
mk-0482
Acute Myeloid Leukemia
Merck Sharp & Dohme LLCP1CC (43)
mk-0482
Chronic Myelomonocytic Leukemia
Merck Sharp & Dohme LLCP1CC (43)
mk-8294
Metastatic Neoplasm
Merck Sharp & Dohme LLCP1CC (43)
Pembrolizumab
Programmed Cell Death 1 Ligand 1(PDL1, PD-L1)
Merck Sharp & Dohme LLCP1CC (43)
Pembrolizumab
Programmed Cell Death 1 Ligand 2 (PDL2, PD-L2)
Merck Sharp & Dohme LLCP1CC (43)
Pembrolizumab
Autoimmune Pulmonary Disease Due To PD-1 Deficiency
Merck Sharp & Dohme LLCP1CC (43)
Sacituzumab Tirumotecan
Programmed Cell Death 1 Ligand 2 (PDL2, PD-L2)
Merck Sharp & Dohme LLCP1CC (43)
Sacituzumab Tirumotecan
Autoimmune Pulmonary Disease Due To PD-1 Deficiency
Merck Sharp & Dohme LLCP1CC (43)
Showing 326 to 350 of 394 assets
PreviousPage 14 of 16Next